Login / Signup

Systematic review and cost-effectiveness of bosentan and sildenafil as therapeutic drugs for pediatric pulmonary arterial hypertension.

Tingting ChenJiahe ChenChaoxin ChenHuanrui ZhengYanhui ChenMaobai LiuBin Zheng
Published in: Pediatric pulmonology (2021)
Based on this model, a more cost-effective treatment drug for PAH in children is sildenafil.
Keyphrases
  • drug induced
  • pulmonary arterial hypertension
  • systematic review
  • pulmonary hypertension
  • pulmonary artery
  • meta analyses
  • young adults
  • randomized controlled trial
  • coronary artery
  • replacement therapy